Breast Pathology Treatment and Drugs

Breast cancer treatment team mainly includes Breast surgeon, surgical oncologist, radiation oncologist, medical oncologist, plastic surgeon. It also includes a variety of other health care professionals, including physician assistants, oncology nurses, social workers, pharmacists, counsellors, nutritionists, and others. The biology and behaviour of a breast cancer affects the treatment plan. Treatment options and recommendations are very personalized and depend on several factors, including: stage of tumour, tumour subtypes, genomic maker, patient age, and patient menopausal status, mutations in inherited breast cancer genes, such as BRCA1 or BRCA2. For both DCIS and early-stage invasive breast cancer, doctors generally perform surgery to remove the tumour. For larger cancers, or those that are growing more quickly, doctors may recommend systemic treatment with chemotherapy or hormonal therapy before surgery, called neoadjuvant therapy.

    Related Conference of Breast Pathology Treatment and Drugs

    October 30-30, 2020

    2nd World Congress on Pathology and Clinical Practice

    Vienna, Austria
    November 25-26, 2020

    18th Asia Pacific Pathology Congress

    Tokyo, Japan
    November 25-26, 2020

    World Congress on Histopathology & Cytopathology

    Kyoto, Japan
    December 07-08, 2020

    7th Annual Meet on Cardiology and Heart diseases

    Prague, Czech Republic

    Breast Pathology Treatment and Drugs Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in